Your browser doesn't support javascript.
loading
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept.
Colen, Rivka R; Fujii, Takeo; Bilen, Mehmet Asim; Kotrotsou, Aikaterini; Abrol, Srishti; Hess, Kenneth R; Hajjar, Joud; Suarez-Almazor, Maria E; Alshawa, Anas; Hong, David S; Giniebra-Camejo, Dunia; Stephen, Bettzy; Subbiah, Vivek; Sheshadri, Ajay; Mendoza, Tito; Fu, Siqing; Sharma, Padmanee; Meric-Bernstam, Funda; Naing, Aung.
Afiliação
  • Colen RR; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rcolen@mdanderson.org.
  • Fujii T; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. rcolen@mdanderson.org.
  • Bilen MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4004, USA.
  • Kotrotsou A; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Abrol S; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hess KR; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Hajjar J; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Suarez-Almazor ME; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alshawa A; Department of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, TX, USA.
  • Hong DS; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Giniebra-Camejo D; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4004, USA.
  • Stephen B; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4004, USA.
  • Subbiah V; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Sheshadri A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4004, USA.
  • Mendoza T; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4004, USA.
  • Fu S; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sharma P; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4004, USA.
  • Naing A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Invest New Drugs ; 36(4): 601-607, 2018 08.
Article em En | MEDLINE | ID: mdl-29075985
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Imunoterapia Tipo de estudo: Etiology_studies / Prognostic_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Imunoterapia Tipo de estudo: Etiology_studies / Prognostic_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos